This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ICAD Reports Third Quarter Financial Results

Third Quarter Financial Results

Revenue: Total revenue for the third quarter of 2011 was $8.1 million, an increase of approximately $2.5 million, or 44%, compared with total revenue of $5.6 million for the third quarter of 2010. The Axxent eBx system contributed approximately $1.8 million to revenue in the quarter, consisting of approximately $1.3 million in product sales and $441,000 in service and supply revenue. In addition, the quarter featured solid growth in the Company’s CAD business.
     
Three months ended September 30,
2011   2010   % Change
Digital & MRI revenue $ 3,791 $ 3,311 15 %
Film based revenue 616 748 (18 )%
Electronic brachytherapy 1,347 - -
Service & supply revenue   2,298     1,527   51 %
Total revenue $ 8,052   $ 5,586   44 %
 

Gross Margin: Gross profit for the third quarter of 2011 was $5.9 million, or 73.1% of revenue, compared with $4.5 million, or 79.8% of revenue, for the third quarter of 2010.

Goodwill Impairment & Contingent Consideration: In the third quarter of 2011, the Company recorded a non-cash charge of $26.8 million related to the impairment of goodwill. As a result of the sustained decline in the market value of the Company, an interim goodwill impairment analysis was performed using the two-step approach, as required under GAAP. The Company concluded that, based on current market conditions, a portion of goodwill was impaired resulting in a $26.8 million non-cash charge in the third quarter of 2011.

In the third quarter of 2011, the Company recorded a non-cash $3.8 million gain on contingent consideration. This gain represents a fair value adjustment to the contingent consideration liability related to the Company’s acquisition of Xoft, Inc. in December 2010.

2 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs